New guidance addresses how to safely use placental tissues in clinical medicine

Regulators and clinicians are establishing clearer standards for using perinatal-derived cell products in patient care. The guidance matters because these therapies show promise for treating serious conditions, but their clinical adoption has been hampered by unclear regulatory pathways and safety requirements.

Originaltitel: Expert Consideration on Regulatory Aspects for Perinatal Derivatives in Clinical Settings